• 

  April 16, 2025

  Cellbricks Reports Preclinical Success with Bioprinted Tissue in Mice

  R.D. Solorzano

• 

  April 16, 2025

  FluidForm Bio Launches $1.24M Crowdfunding Round to Advance Bioprinted Diabetes Therapy

  R.D. Solorzano

• 

  April 8, 2025

  Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs

  R.D. Solorzano

• 

  April 3, 2025

  Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

  R.D. Solorzano

• 

  April 3, 2025

  LyGenesis Receives Green Light to Advance Organ Regeneration Trial

  R.D. Solorzano

• 

  March 18, 2025

  How Cellino and Matricelf are Advancing Neural Tissue Engineering

  R.D. Solorzano

• 

  March 18, 2025

  CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program

  R.D. Solorzano

• 

  March 18, 2025

  Vericel – Poised for Growth with Expanding Indications and Strong Margins

  R.D. Solorzano

• 

  March 7, 2025

  Sernova Biotherapeutics Secures FDA Clearance for Thyroid Cell Pouch IND Application

  R.D. Solorzano

• 

  March 7, 2025

  Nurami Medical Secures $30 Million to Accelerate Meningeal Tissue Repair Innovation

  R.D. Solorzano